HK Stock MarketDetailed Quotes
01875 TOT BIOPHARM-B
- 1.740
- 0.0000.00%
Market Closed Nov 15 16:08 CST
1.34BMarket Cap133.85P/E (TTM)
0.000High0.000Low0Volume1.740Open1.740Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)772.79MShares2.79052wk High1.70P/B1.34BFloat Cap1.48052wk Low--Dividend TTM772.79MShs Float6.430Historical High--Dividend LFY0.00%Amplitude0.800Historical Low--Avg Price400Lot Size--Div YieldTTM--Div Yield LFY
TOT BIOPHARM-B Key Stats
EPS
According to the latest financial report of TOT BIOPHARM-B, the latest earnings per share (TTM) for the company is 0.04. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out TOT BIOPHARM-B's latest financial report to see how much their book value per share (BVPS) is currently at 1.03.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of TOT BIOPHARM-B shows that the company's current ratio is 1.94, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of TOT BIOPHARM-B, the quick ratio is 1.63, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of TOT BIOPHARM-B? The latest ROE figure is 4.46%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of TOT BIOPHARM-B, the total asset return on investment (ROA) is 2.18%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check TOT BIOPHARM-B's latest financial report to see how their gross margin is doing - currently at 72.40%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of TOT BIOPHARM-B, the net profit margin is 6.06%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data